Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 1/20 | 0.46 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.46 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.42 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1077180 | 1.00 | EGFR (0.46) | EGFRERBB2SRD5A2MEN1KMT2A | |
| SCHEMBL948749 | 0.91 | SRD5A2 (0.46) | EGFRERBB2SRD5A2MEN1KMT2A | |
| SCHEMBL948748 | 0.91 | SRD5A2 (0.46) | EGFRERBB2SRD5A2MEN1KMT2A | |
| SCHEMBL949756 | 0.85 | SRD5A2 (0.52) | EGFRERBB2SRD5A2MEN1KMT2A | |
| SCHEMBL949755 | 0.85 | SRD5A2 (0.52) | EGFRERBB2SRD5A2MEN1KMT2A | |
| SCHEMBL946360 | 0.77 | SRD5A2 (0.51) | SRD5A2MEN1KMT2ANPC1RAB9A | |
| SCHEMBL946357 | 0.77 | SRD5A2 (0.51) | SRD5A2MEN1KMT2ANPC1RAB9A | |
| SCHEMBL946768 | 0.76 | SRD5A2 (0.46) | EGFRERBB2SRD5A2MEN1KMT2A | |
| SCHEMBL946767 | 0.76 | SRD5A2 (0.46) | EGFRERBB2SRD5A2MEN1KMT2A | |
| SCHEMBL1040359 | 0.75 | GABRA1 (0.48) | SRD5A2MEN1KMT2AHSP90AA1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011005295-A1 | MODULATORS OF THE SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2011-01-13 | — | — | WO | disclosed |